AU
AUSAF.US Australis Capital Inc
- Market cap
- USD 2.78K
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2023.
Is AUSAF.US undervalued?
Graham numberThe Graham number of Australis Capital Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Australis Capital Inc fundamental analysis
No fundamental analysis for Australis Capital Inc yet.
Australis Capital Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Australis Capital Inc
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
Full company profileAustralis Capital Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Australis Capital Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0.00 | 0.00 | 130K | 221K | 717K | 7.57M | - |
| Gross Profit | 0.00 | 0.00 | 127K | 222.00 | -203K | 3.97M | - |
| Operating Income | -5.34K | -1.04K | -4.29M | -14.4M | -14.0M | -19.4M | - |
| EBITDA | -63.5K | 47.8K | -4.12M | -22.5M | -24.6M | -14.1M | - |
| Net Income | -37.9K | -42.7K | -4.17M | -23.3M | -25.3M | -50.1M | - |
| EPS | 0.00 | 0.00 | -0.04 | -0.14 | -0.14 | -0.20 | - |
| Balance Sheet | |||||||
| Total Assets | 1.36M | 3.01M | 65.1M | 63.7M | 65.6M | 50.6M | - |
| Total Liabilities | 74.98 | 3.17M | 4.38M | 5.93M | 12.5M | 14.2M | - |
| Shareholders' Equity | 1.29M | -163K | 60.7M | 57.8M | 48.8M | 20.9M | - |
| Cash & Short-term Investments | 413.90 | 0.00 | 8.50M | 9.20M | 2.81M | 582K | - |
| Total Debt | 1.81M | 3.14M | 142K | 752K | 1.89M | 2.45M | - |
| Cash Flow | |||||||
| Operating Cash Flow | 413.90 | -619.00 | -2.81M | -8.32M | -9.47M | -11.3M | - |
| Capital Expenditure | 131K | 131K | 131K | 1.20M | 1.18M | 11.3M | - |
| Free Cash Flow | 413.90 | -619.00 | -2.94M | -9.52M | -8.71M | -11.3M | - |
| Ratios | |||||||
| ROE | -2.9% | - | -6.9% | -40.4% | -51.8% | -239.1% | - |
| ROA | -2.8% | -1.4% | -6.4% | -36.6% | -38.5% | -99.0% | - |
| Net Profit Margin | - | - | -3,214.4% | -10,539.0% | -3,522.4% | -661.5% | - |
| Debt to Equity | 1.40x | - | 0.00x | 0.01x | 0.04x | 0.12x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Australis Capital Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2022 | - | - | - |
| 2021 | CAD 160K | 0.00 | - |
| 2020 | CAD 1.89M | 0.01 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Australis Capital Inc
Ownership data of Australis Capital Inc is not available yet.
Australis Capital Inc company profile
- Company name
- Australis Capital Inc
- Ticker
- AUSAF.US
- ISIN
- CA05259R1073
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- March
- Address
- 376 East Warm Springs Road, Las Vegas, NV, United States, 89119
- Phone
- 800 898 0648
- Website
- ausacap.com
About Australis Capital Inc
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
Australis Capital Inc management
9- Mr. Terrance R. BoothCEO & Director · born 1965
- Dr. Jason Ronald Bradley Dyck Ph.D.Chief Science Officer, Chairman of Scientific Advisory Board & Director · born 1969
- Mr. Robert WilsonChief Financial Officer · born 1961
- Mr. Roger SykesChief Operating Officer
- Mr. Paul E. LarsenGeneral Counsel
- Mr. Marc LakmaakerSenior VP of Communications & Capital Markets
- Mr. Fausto Aceituno AceitunoChief Marketing Officer
- Mr. W. Campbell Birge B.A., BED, M.Sc.Strategic Advisor · born 1953
- Mr. Randon MarcosDirector of Business Development